vs
Side-by-side financial comparison of Broadway Financial Corp (BYFC) and Invivyd, Inc. (IVVD). Click either name above to swap in a different company.
Invivyd, Inc. is the larger business by last-quarter revenue ($17.2M vs $9.4M, roughly 1.8× Broadway Financial Corp). Broadway Financial Corp runs the higher net margin — 1934.0% vs -64.3%, a 1998.3% gap on every dollar of revenue. On growth, Invivyd, Inc. posted the faster year-over-year revenue change (24.5% vs 10.1%).
Virtu Financial, Inc. is an American high-frequency trading company. The company went public on the Nasdaq in 2015.
Invivyd, Inc. is a clinical-stage biopharmaceutical company focused on developing broadly neutralizing antibody therapies to prevent and treat serious viral infectious diseases. Its core research and development pipeline targets high-burden respiratory pathogens including respiratory syncytial virus, catering to unmet medical needs of global patient groups.
BYFC vs IVVD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.4M | $17.2M |
| Net Profit | $1.0M | $-11.1M |
| Gross Margin | — | — |
| Operating Margin | — | -73.0% |
| Net Margin | 1934.0% | -64.3% |
| Revenue YoY | 10.1% | 24.5% |
| Net Profit YoY | -21.8% | 40.0% |
| EPS (diluted) | $0.02 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.4M | $17.2M | ||
| Q3 25 | $9.0M | $13.1M | ||
| Q2 25 | $8.1M | $11.8M | ||
| Q1 25 | $8.3M | $11.3M | ||
| Q4 24 | $8.6M | $13.8M | ||
| Q3 24 | $8.7M | $9.3M | ||
| Q2 24 | $8.2M | $2.3M | ||
| Q1 24 | $7.8M | $0 |
| Q4 25 | $1.0M | $-11.1M | ||
| Q3 25 | $-23.9M | $-10.5M | ||
| Q2 25 | $752.0K | $-14.7M | ||
| Q1 25 | $-2.7M | $-16.3M | ||
| Q4 24 | $1.3M | $-18.4M | ||
| Q3 24 | $516.0K | $-60.7M | ||
| Q2 24 | $256.0K | $-47.2M | ||
| Q1 24 | $-154.0K | $-43.5M |
| Q4 25 | — | -73.0% | ||
| Q3 25 | -256.2% | -84.0% | ||
| Q2 25 | 12.8% | -127.8% | ||
| Q1 25 | -45.3% | -149.7% | ||
| Q4 24 | 21.7% | -139.1% | ||
| Q3 24 | 8.5% | -670.0% | ||
| Q2 24 | 4.8% | -2175.2% | ||
| Q1 24 | -2.9% | — |
| Q4 25 | 1934.0% | -64.3% | ||
| Q3 25 | -264.2% | -79.7% | ||
| Q2 25 | 9.3% | -124.4% | ||
| Q1 25 | -32.3% | -144.1% | ||
| Q4 24 | 15.3% | -133.5% | ||
| Q3 24 | 5.9% | -653.1% | ||
| Q2 24 | 3.1% | -2086.9% | ||
| Q1 24 | -2.0% | — |
| Q4 25 | $0.02 | $0.02 | ||
| Q3 25 | $-2.86 | $-0.06 | ||
| Q2 25 | $0.00 | $-0.12 | ||
| Q1 25 | $-0.39 | $-0.14 | ||
| Q4 24 | $0.07 | $-0.14 | ||
| Q3 24 | $-0.03 | $-0.51 | ||
| Q2 24 | $0.02 | $-0.40 | ||
| Q1 24 | $-0.02 | $-0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.5M | $226.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $262.8M | $241.5M |
| Total Assets | $1.3B | $276.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.5M | $226.7M | ||
| Q3 25 | $19.7M | $85.0M | ||
| Q2 25 | $29.5M | $34.9M | ||
| Q1 25 | $15.8M | $48.1M | ||
| Q4 24 | $61.4M | $69.3M | ||
| Q3 24 | $97.1M | $106.9M | ||
| Q2 24 | $89.8M | $147.9M | ||
| Q1 24 | $67.1M | $189.4M |
| Q4 25 | $262.8M | $241.5M | ||
| Q3 25 | $261.7M | $93.1M | ||
| Q2 25 | $284.7M | $42.8M | ||
| Q1 25 | $283.6M | $54.1M | ||
| Q4 24 | $285.0M | $67.5M | ||
| Q3 24 | $286.2M | $83.2M | ||
| Q2 24 | $282.1M | $140.6M | ||
| Q1 24 | $281.1M | $178.5M |
| Q4 25 | $1.3B | $276.9M | ||
| Q3 25 | $1.3B | $139.2M | ||
| Q2 25 | $1.2B | $89.1M | ||
| Q1 25 | $1.3B | $103.7M | ||
| Q4 24 | $1.3B | $129.5M | ||
| Q3 24 | $1.4B | $161.9M | ||
| Q2 24 | $1.4B | $177.3M | ||
| Q1 24 | $1.4B | $215.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $230.0K | $-15.5M |
| Free Cash FlowOCF − Capex | $-13.0K | — |
| FCF MarginFCF / Revenue | -0.1% | — |
| Capex IntensityCapex / Revenue | 2.6% | 0.0% |
| Cash ConversionOCF / Net Profit | 0.22× | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $230.0K | $-15.5M | ||
| Q3 25 | $3.8M | $-8.3M | ||
| Q2 25 | $3.0M | $-13.3M | ||
| Q1 25 | $-4.3M | $-21.1M | ||
| Q4 24 | $1.4M | $-37.6M | ||
| Q3 24 | $6.1M | $-41.1M | ||
| Q2 24 | $9.8M | $-41.6M | ||
| Q1 24 | $-11.7M | $-50.2M |
| Q4 25 | $-13.0K | — | ||
| Q3 25 | $3.7M | — | ||
| Q2 25 | $3.0M | $-13.3M | ||
| Q1 25 | $-4.4M | $-21.3M | ||
| Q4 24 | $1.3M | $-37.6M | ||
| Q3 24 | $6.1M | $-41.1M | ||
| Q2 24 | $9.7M | — | ||
| Q1 24 | $-11.7M | $-50.4M |
| Q4 25 | -0.1% | — | ||
| Q3 25 | 41.1% | — | ||
| Q2 25 | 37.0% | -112.9% | ||
| Q1 25 | -52.4% | -188.2% | ||
| Q4 24 | 14.7% | -272.2% | ||
| Q3 24 | 69.6% | -441.6% | ||
| Q2 24 | 118.9% | — | ||
| Q1 24 | -149.7% | — |
| Q4 25 | 2.6% | 0.0% | ||
| Q3 25 | 1.2% | 0.0% | ||
| Q2 25 | 0.2% | 0.1% | ||
| Q1 25 | 0.2% | 1.3% | ||
| Q4 24 | 1.6% | 0.0% | ||
| Q3 24 | 0.3% | 0.1% | ||
| Q2 24 | 0.5% | 0.0% | ||
| Q1 24 | 0.7% | — |
| Q4 25 | 0.22× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.00× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.06× | — | ||
| Q3 24 | 11.85× | — | ||
| Q2 24 | 38.21× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
